Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with the corresponding text and a Home button, indicating that access to the study record is blocked and the normal study details are not available.
    Difference
    0.5%
    Check dated 2026-09-29T08:39:43.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the full study details with an access-denied screen. The UI shows the error text and basic navigation (including Home and Revision: v3.7.0), while the substantive study information has been removed.
    Difference
    19%
    Check dated 2026-09-22T07:56:04.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.6, replacing the previous v3.6.5. This indicates a minor update to the page's revision tag, with no changes to the study details or criteria.
    Difference
    0.1%
    Check dated 2026-08-31T23:48:13.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.4 to v3.6.5, signaling a new build of the study details page. The update appears to be a backend or layout revision without changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-10T11:57:14.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, signaling a minor platform update. No study data or text across the page appears to have changed.
    Difference
    0.1%
    Check dated 2026-07-27T06:18:33.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The study record now shows revision v3.6.3, replacing the previous v3.6.2. This indicates a minor editorial update to the page rather than a change to the trial details.
    Difference
    0.1%
    Check dated 2026-07-05T14:39:32.000Z thumbnail image

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.